STOK
Stoke Therapeutics Inc
NASDAQ: STOK · HEALTHCARE · BIOTECHNOLOGY
$32.42
-2.73% today
Updated 2026-04-29
Market cap
$1.92B
P/E ratio
—
P/S ratio
10.40x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$8 – $40
Volume
0.8M
Stoke Therapeutics Inc (STOK) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |